Generation Bio Co (GBIO)
3.64
-0.13
(-3.45%)
USD |
NASDAQ |
May 17, 16:00
3.64
0.00 (0.00%)
After-Hours: 20:00
Generation Bio Shareholders Equity (Quarterly): 131.99M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 131.99M |
December 31, 2023 | 203.13M |
September 30, 2023 | 231.91M |
June 30, 2023 | 254.29M |
March 31, 2023 | 279.14M |
December 31, 2022 | 282.49M |
September 30, 2022 | 308.75M |
June 30, 2022 | 324.87M |
March 31, 2022 | 352.92M |
Date | Value |
---|---|
December 31, 2021 | 381.75M |
September 30, 2021 | 407.21M |
June 30, 2021 | 433.40M |
March 31, 2021 | 458.74M |
December 31, 2020 | 268.01M |
September 30, 2020 | 286.54M |
June 30, 2020 | 304.15M |
March 31, 2020 | 109.77M |
December 31, 2019 | -98.59M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-98.59M
Minimum
Dec 2019
458.74M
Maximum
Mar 2021
273.36M
Average
284.52M
Median
Shareholders Equity (Quarterly) Benchmarks
Quantum-Si Inc | 253.77M |
CEL-SCI Corp | 14.30M |
AIM ImmunoTech Inc | 10.23M |
IGC Pharma Inc | 9.053M |
NovaBay Pharmaceuticals Inc | 0.16M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 285.88M |
Total Liabilities (Quarterly) | 153.89M |
Current Ratio | 8.013 |